Vesica Health, Inc. — Form D
Vesica Health, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-17. The offering totals $4.6M, of which $4.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-17
- Form: D
- Accession: 0002114321-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.6M
- Amount sold: $4.5M
- Remaining: $163K
- Investors: 12
- Date of first sale: 2026-03-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576760
Issuer
- Name: Vesica Health, Inc.
- CIK: 0002114321
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 5 MASON LANE, IRVINE, CA, 92618
- Phone: 303-885-3719
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jan Groen | Director | Irvine, CA |
| Mark McDonough | Director | Irvine, CA |
| Joseph Sollee | Director | Irvine, CA |
| Christopher Thibodeau | Director | Irvine, CA |
| Laura Caba | Executive Officer | Irvine, CA |
| Christopher Thibodeau | Executive Officer | Irvine, CA |
More